Functional drug response profiling predicts clinical outcomes and shows utility for treatment stratification in AMLAleksej Drino, Nikolaus Krall, Rebecca Kirkley et al.|Blood|2025Cited by 0
EZH2 inactivation drives MAPK-dependent vulnerability to MEK inhibition in RAS-mutant CMMLEva Gruden, Armin Zebisch, Bianca Perfler et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0